Suzuki Yosuke 鈴木陽介

Researcher Number	10737191
Other IDs
Affiliation (Current)	2025: 明治薬科大学, 薬学部, 講師
Affiliation (based on the past Project Information) *help	2021 – 2025: 明治薬科大学, 薬学部, 講師 2019 – 2020: 明治薬科大学, 薬学部, 助教 2017: 大分大学, 医学部, 薬剤主任 2016: 大分大学, 医学部, 薬物動態解析室主任 2015: 大分大学, 医学部, 客員研究員
Review Section/Research Field	Principal Investigator Basic Section 47060:Clinical pharmacy-related / Basic Section 58020:Hygiene and public health-related: including laboratory approach / Medical pharmacy Except Principal Investigator Basic Section 47060:Clinical pharmacy-related / Medical pharmacy
Keywords	Principal Investigator 薬物動態 / バイオマーカー / 慢性腎不全 / メタボローム解析 / ゲノムワイド関連解析 / 関節リウマチ / 慢性腎臓病 / CMPF / coproporphyrin-I / フェノタイピング … More / OATP1B / トランスポーター / 代謝 / 腎移植 / CYP3A5 / 3-indoxyl sulfate / Phenoconversion / CYP3A … More Except Principal Investigator バイオマーカー / MR-proADM / 生理学的薬物速度論解析 / アニフロルマブ / ベリムマブ / 全身性エリトマトーデス / ファーマコメトリクス / 血管炎症候群 / ANCA関連血管炎 / CT-proAVP / CT-proET-1 / MR-proANP / 酵素免疫測定法 / 腎移植 / 慢性腎不全 / 降圧治療抵抗性 Less

日本における有機フッ素化合物とがん罹患リスクの解明に関するコホート内症例対照研究Principal Investigator
- Principal Investigator
  
  鈴木陽介
- Project Period (FY)
  2025 – 2028
- Research Category
  
  Grant-in-Aid for Scientific Research (B)
- Review Section
  
  Basic Section 58020:Hygiene and public health-related: including laboratory approach
- Research Institution
  Meiji Pharmaceutical University
Clinical pharmacology studies to explore the optimal therapeutic strategy of novel antibody agents in systemic lupus erythematosus
- Principal Investigator
  
  田中遼大
- Project Period (FY)
  2024 – 2027
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 47060:Clinical pharmacy-related
- Research Institution
  Oita University
ゲノム・オミックス情報を駆使した薬物動態関連バイオマーカーの網羅的探索研究Principal Investigator
- Principal Investigator
  
  鈴木陽介
- Project Period (FY)
  2022 – 2024
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 47060:Clinical pharmacy-related
- Research Institution
  Meiji Pharmaceutical University
Development of useful new biomarkers to predict the severity and prognosis of vasculitis syndrome
- Principal Investigator
  
  伊東弘樹
- Project Period (FY)
  2022 – 2024
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 47060:Clinical pharmacy-related
- Research Institution
  Oita University
Physiological factors involved in variability of OATP1B activityPrincipal Investigator
- Principal Investigator
  
  Suzuki Yosuke
- Project Period (FY)
  2019 – 2021
- Research Category
  
  Grant-in-Aid for Early-Career Scientists
- Review Section
  
  Basic Section 47060:Clinical pharmacy-related
- Research Institution
  Meiji Pharmaceutical University
Establishment of MR-proADM as novel biomarker for individualization of antihypertensive therapy in renal failure patient
- Principal Investigator
  
  Itoh Hiroki
- Project Period (FY)
  2015 – 2017
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Medical pharmacy
- Research Institution
  Oita University
Significant factors associated with the decrease in CYP3A activity in patients with chronic renal failurePrincipal Investigator
- Principal Investigator
  
  Suzuki Yosuke
- Project Period (FY)
  2015 – 2016
- Research Category
  
  Grant-in-Aid for Young Scientists (B)
- Research Field
  
  Medical pharmacy
- Research Institution
  Oita University

All 2024 2023 2021 2020 2017 2015

All Journal Article Presentation

[Journal Article] Factors Influencing Plasma Coproporphyrin-I Concentration as Biomarker of OATP1B Activity in Patients With Rheumatoid Arthritis2021
- Author(s)
  Ono H, Tanaka R, Suzuki Y, Oda A, Ozaki T, Tatsuta R, Maeshima K, Ishii K, Ohno K, Shibata H, Itoh H.
- Journal Title
  
  Clin Pharmacol Ther
  
  Volume: 110 Issue: 4 Pages: 1096-1105
- DOI
  10.1002/cpt.2375
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-19K16455, KAKENHI-PROJECT-20K16048
[Journal Article] Relationship of Hemoglobin Level and Plasma Coproporphyrin-I Concentrations as an Endogenous Probe for Phenotyping OATP1B2021
- Author(s)
  Suzuki Y, Sasamoto Y, Koyama T, Yoshijima C, Oda A, Nakatochi M, Kubo M, Momozawa Y, Uehara R, Ohno K
- Journal Title
  
  Clin Transl Sci
  
  Volume: - Issue: 4 Pages: 1403-1411
- DOI
  10.1111/cts.12996
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-19K16455, KAKENHI-PROJECT-16H06277
[Journal Article] Substantially Increased Plasma Coproporphyrin-I Concentrations Associated With OATP1B1*15 Allele in Japanese General Population2021
- Author(s)
  Suzuki Y, Sasamoto Y, Koyama T, Yoshijima C, Nakatochi M, Kubo M, Momozawa Y, Uehara R, Ohno K
- Journal Title
  
  Clin Transl Sci
  
  Volume: 14 Issue: 1 Pages: 382-388
- DOI
  10.1111/cts.12889
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-19K16455, KAKENHI-PROJECT-16H06277
[Journal Article] Simultaneous quantification of coproporphyrin-I and 3-carboxy-4-methyl-5-propyl-2-furanpropanoic acid in human plasma using ultra-high performance liquid chromatography coupled to tandem mass spectrometry2020
- Author(s)
  Suzuki Y, Sasamoto Y, Yoshijima C, Tanaka R, Ono H, Ando T, Shin T, Mimata H, Itoh H, Ohno K
- Journal Title
  
  Journal of Pharmaceutical and Biomedical Analysis
  
  Volume: 184 Pages: 113202-113202
- DOI
  10.1016/j.jpba.2020.113202
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-19K16455
[Journal Article] Association of metabolic complication with plasma mid-regional pro adrenomedullin level in stable kidney transplant recipients2015
- Author(s)
  Suzuki Y, Katagiri F, Sato F, Fujioka T, Tanaka R, Sato Y, Mimata H, Itoh H
- Journal Title
  
  Clin. Chim. Acta
  
  Volume: 453 Pages: 160-163
- DOI
  10.1016/j.cca.2015.12.016
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-15K08101
[Journal Article] CYP3A5 polymorphism affects the increase in CYP3A activity after living kidney transplantation in patients with end stage renal disease.2015
- Author(s)
  Suzuki Y, Fujioka T, Sato F, Matsumoto K, Muraya N, Tanaka R, Sato Y, Ohno K, Mimata H, Kishino S, Itoh H.
- Journal Title
  
  Br J Clin Pharmacol
  
  Volume: 80(6) Issue: 6 Pages: 1421-1428
- DOI
  10.1111/bcp.12733
- Peer Reviewed / Acknowledgement Compliant
- Data Source
  KAKENHI-PROJECT-15K18926
[Presentation] ゲノムワイド関連解析とメタボローム解析によるcytochrome P450 2D6 の新規バイオマーカーの探索　～逆相-強陰イオン交換ミックスモードによる固相抽出法での検討～2024
- Author(s)
  神尾奈月、鈴木陽介、飯野滉大、鈴木さくら、山岸尚、小山晃英、小田絢子、大野恵子
- Organizer
  日本薬学会第144年会
- Data Source
  KAKENHI-PROJECT-22K06706
[Presentation] ゲノムワイド関連解析とメタボローム解析を用いたcytochrome P450 3A5の内在性バイオマーカーの探索　～逆相-強陰イオン交換ミックスモードによる固相抽出法による検討～2024
- Author(s)
  山岸尚、鈴木陽介、飯野滉大、鈴木さくら、神尾奈月、小山晃英、小田絢子、大野恵子
- Organizer
  日本薬学会第144年会
- Data Source
  KAKENHI-PROJECT-22K06706
[Presentation] ゲノムワイド関連解析とメタボローム解析によるcytochrome P450 2C19の内在性バイオマーカーの探索　～逆相-強陰イオン交換ミックスモードによる固相抽出法での検討～2024
- Author(s)
  鈴木さくら、鈴木陽介、飯野滉大、山岸尚、神尾奈月、小山晃英、小田絢子、大野恵子
- Organizer
  日本薬学会第144年会
- Data Source
  KAKENHI-PROJECT-22K06706
[Presentation] ゲノムワイド関連解析とメタボローム解析によるOATP1B1活性を評価する新規バイオマーカーの探索　～逆相-強陰イオン交換ミックスモードによる固相抽出法での検討～2024
- Author(s)
  飯野滉大、鈴木陽介、鈴木さくら、山岸尚、神尾奈月、小田絢子、小山晃英、大野恵子
- Organizer
  日本薬学会第144年会
- Data Source
  KAKENHI-PROJECT-22K06706
[Presentation] 血液悪性腫瘍患者を対象とした発熱性好中球減少症時におけるMR-proADMの推移および他の感染マーカ―との関連性の評価2023
- Author(s)
  岩男　元志、田中　遼大、白岩　健、末繁　嘉朗、鈴木　陽介、髙野　久仁子、龍田　涼佑、緒方　正男、伊東　弘樹
- Organizer
  第44回日本臨床薬理学会学術総会
- Data Source
  KAKENHI-PROJECT-22K06770
[Presentation] 関節リウマチ患者における血漿Coproporphyrin-I濃度を指標としたOATP1B活性個人差の要因解析2021
- Author(s)
  小野寛之, 田中遼大, 鈴木陽介, 小田絢子, 尾崎貴士, 龍田涼佑, 大野恵子, 柴田洋孝, 伊東弘樹
- Organizer
  第31回日本医療薬学会年会
- Data Source
  KAKENHI-PROJECT-19K16455
[Presentation] 血漿中コプロポルフィリンI濃度を用いた関節リウマチ患者のOATP1B活性に影響を与える因子の探索2021
- Author(s)
  小野寛之, 田中遼大, 鈴木陽介, 小田絢子, 尾崎貴士, 龍田涼佑, 大野恵子, 柴田洋孝, 伊東弘樹
- Organizer
  第15回次世代を担う若手のための医療薬科学シンポジウム
- Data Source
  KAKENHI-PROJECT-19K16455
[Presentation] UHPLC-MS/MS法による血漿中coproporphyrin-Iの定量法の確立2020
- Author(s)
  笹本雄理、鈴木陽介、吉島千智、田中遼大、小野寛之、秦聡孝、三股浩光、伊東弘樹、大野恵子
- Organizer
  日本薬学会第140年会
- Data Source
  KAKENHI-PROJECT-19K16455
[Presentation] Substantially increased plasma coproporphyrin-I concentrations associated with OATP1B1*15 allele in Japanese general population2020
- Author(s)
  Suzuki Y, Sasamoto Y, Koyama T, Yoshijima C, Ohno K
- Organizer
  18th International Congress of Therapeutic Drug Monitoring & Clinical Toxicology
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-19K16455
[Presentation] 生体腎移植後の降圧薬治療強度を予測する因子の探索2017
- Author(s)
  鈴木　陽介
- Organizer
  第38回日本臨床薬理学会学術総会
- Data Source
  KAKENHI-PROJECT-15K08101
[Presentation] Phenoconversion of CYP3A in chronic renal failure; what is the factor involved?2017
- Author(s)
  Suzuki Y, Muraya N, Fujioka T, Sato F, Tanaka R, Matsumoto K, Sato Y, Ohno K, Mimata H, Kishino S, Itoh H
- Organizer
  15th International Congress of Therapeutic Drug Monitoring & Clinical Toxicology
- Place of Presentation
  Kyoto International Conference Center, Kyoto, Japan
- Year and Date
  2017-09-24
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-15K18926
[Presentation] 腎機能障害時におけるCYP3AのPhenoconversionに関連する因子の探索2015
- Author(s)
  村谷菜々子、鈴木陽介、藤岡孝志、佐藤文憲、松本邦洋、田中遼大、佐藤雄己、大野恵子、三股浩光、岸野吏志、伊東弘樹
- Organizer
  第36回日本臨床薬理学会学術総会
- Place of Presentation
  京王プラザホテル新宿（東京都新宿区）
- Year and Date
  2015-12-09
- Data Source
  KAKENHI-PROJECT-15K18926
[Presentation] CYP3A5遺伝子多型およびインドキシル硫酸の蓄積が生体腎移植後のCYP3A活性の回復に与える影響2015
- Author(s)
  村谷菜々子、鈴木陽介、藤岡孝志、佐藤文憲、松本邦洋、田中遼大、佐藤雄己、大野恵子、三股浩光、岸野吏志、伊東弘樹
- Organizer
  第25回日本医療薬学会年会
- Place of Presentation
  パシフィコ横浜（神奈川県横浜市）
- Year and Date
  2015-11-21
- Data Source
  KAKENHI-PROJECT-15K18926
[Presentation] 安定期生体腎移植患者における移植後のeGFRの低下に関連する因子の検討2015
- Author(s)
  村谷菜々子、鈴木陽介、藤岡孝志、佐藤雄己、伊東弘樹
- Organizer
  医療薬学フォーラム2015/第23回クリニカルファーマシーシンポジウム
- Place of Presentation
  名古屋国際会議場（愛知県、名古屋市）
- Year and Date
  2015-07-04
- Data Source
  KAKENHI-PROJECT-15K08101
[Presentation] CYP3A5 Polymorphism Affects the Increase in CYP3A Activity after Living Kidney Transplantation in Patients with End Stage Renal Disease.2015
- Author(s)
  Suzuki Y, Fujioka T, Sato F, Matsumoto K, Muraya N, Tanaka R, Sato Y, Ohno K, Mimata H, Kishino S, Itoh H.
- Organizer
  The 12th Congress of the European Association for Clinical Pharmacology and Therapeutics
- Place of Presentation
  Melia Castilla Hotel, Madrid, Spain
- Year and Date
  2015-06-27
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-15K18926
[Presentation] CYP3A5 polymorphism and accumulation of indoxyl sulfate affect the rate of increase in CYP3A activity after living kidney transplantation in patients with end stage renal disease.2015
- Author(s)
  Suzuki Y, Fujioka T, Muraya N, Sato F, Matsumoto K, Tanaka R, Sato Y, Ohno K, Mimata H, Kishino S, Itoh H.
- Organizer
  14th International Congress of Therapeutic Drug Monitoring & Clinical Toxicology
- Place of Presentation
  Congress Centre De Doelen, Rotterdam, The Netherlands
- Year and Date
  2015-10-11
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-15K18926

1. 田中遼大 (30781736)

# of Collaborated Projects: 3 results

# of Collaborated Products: 1 results
2. Itoh Hiroki (50420641)

# of Collaborated Projects: 2 results

# of Collaborated Products: 3 results
3. 小山晃英 (40711362)

# of Collaborated Projects: 1 results

# of Collaborated Products: 4 results
4. 白岩健 (40875077)

# of Collaborated Projects: 1 results

# of Collaborated Products: 1 results

Suzuki Yosuke 鈴木 陽介

Research Projects

Research Products

Co-Researchers

日本における有機フッ素化合物とがん罹患リスクの解明に関するコホート内症例対照研究Principal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Clinical pharmacology studies to explore the optimal therapeutic strategy of novel antibody agents in systemic lupus erythematosus

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

ゲノム・オミックス情報を駆使した薬物動態関連バイオマーカーの網羅的探索研究Principal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Development of useful new biomarkers to predict the severity and prognosis of vasculitis syndrome

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Physiological factors involved in variability of OATP1B activityPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Establishment of MR-proADM as novel biomarker for individualization of antihypertensive therapy in renal failure patient

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Significant factors associated with the decrease in CYP3A activity in patients with chronic renal failurePrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

[Journal Article] Factors Influencing Plasma Coproporphyrin-I Concentration as Biomarker of OATP1B Activity in Patients With Rheumatoid Arthritis2021

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Relationship of Hemoglobin Level and Plasma Coproporphyrin-I Concentrations as an Endogenous Probe for Phenotyping OATP1B2021

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Substantially Increased Plasma Coproporphyrin-I Concentrations Associated With OATP1B1*15 Allele in Japanese General Population2021

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Simultaneous quantification of coproporphyrin-I and 3-carboxy-4-methyl-5-propyl-2-furanpropanoic acid in human plasma using ultra-high performance liquid chromatography coupled to tandem mass spectrometry2020

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Association of metabolic complication with plasma mid-regional pro adrenomedullin level in stable kidney transplant recipients2015

Author(s)

Journal Title

DOI

Data Source

[Journal Article] CYP3A5 polymorphism affects the increase in CYP3A activity after living kidney transplantation in patients with end stage renal disease.2015

Author(s)

Journal Title

DOI

Data Source

[Presentation] ゲノムワイド関連解析とメタボローム解析によるcytochrome P450 2D6 の新規バイオマーカーの探索 ～逆相-強陰イオン交換ミックスモードによる固相抽出法での検討～2024

Author(s)

Organizer

Data Source

Suzuki Yosuke 鈴木陽介

[Presentation] ゲノムワイド関連解析とメタボローム解析によるcytochrome P450 2D6 の新規バイオマーカーの探索　～逆相-強陰イオン交換ミックスモードによる固相抽出法での検討～2024

[Presentation] ゲノムワイド関連解析とメタボローム解析を用いたcytochrome P450 3A5の内在性バイオマーカーの探索　～逆相-強陰イオン交換ミックスモードによる固相抽出法による検討～2024

[Presentation] ゲノムワイド関連解析とメタボローム解析によるcytochrome P450 2C19の内在性バイオマーカーの探索　～逆相-強陰イオン交換ミックスモードによる固相抽出法での検討～2024

[Presentation] ゲノムワイド関連解析とメタボローム解析によるOATP1B1活性を評価する新規バイオマーカーの探索　～逆相-強陰イオン交換ミックスモードによる固相抽出法での検討～2024